Business & Finance
Business and Finance
Business and Finance
Tue, August 3, 2010
Mon, August 2, 2010 
HOUSTON--([ BUSINESS WIRE ])--Emerging Healthcare Solutions, Inc. (Pink Sheets: EHSI) disclosed today that the Company has executed a Term Sheet with Stand-By Systems. The Term Sheet represents successful negotiations between the two companies just ahead of finalizing a Definitive Agreement. Stand-By Systems (SBS) owns the FDA approved SBS 1615 catalytic oxygen generator and associated systems. This cutting edge generator provides medical grade USP oxygen at the push of a button from self-contained inert dry compounds. Stand-By Systems intends to make this portable personal life-saving device (smaller than the size of a soft drink can) become as common in everyday life as household fire extinguishers, smoke detectors and first-aid kits. The Term Sheet is pursuant to an option between the two companies that was executed and announced on May 10th.
According to the American Heart Association, 87.5 million Americans are at risk of heart attack or stroke with the critical need for oxygen even before 911/EMS can respond. Stand-By Systema™s research leads the company to believe that the critical-need domestic market could translate into a multibillion dollar business.
The first of several oxygen delivery systems using the SBS 1615 catalytic oxygen generator is called LIFEDGE®, which is scheduled for pilot scale production. LIFEDGE® is a lightweight, on demand dispenser of emergency-duration medical grade oxygen, created by the SBS 1615 catalytic oxygen generator. There is no other technologically equivalent product available today. The LIFEDGE® prototype is complete and is trademarked and protected by multiple patents.
Another Stand-By Systems product for use with the SBS 1615 catalytic oxygen generator is the MAYDAY®, which is an emergency personnel escape system (self-contained breathing apparatus). The MAYDAY® is expected to replace technologically obsolete devices currently deployed within the military, in sensitive governmental installations and in industrial plants.
Emerging Healthcare Solutions focuses on the development of profitable emerging medical technology, a sector that also includes Johnson & Johnson (NYSE: JNJ), Human Genome Sciences, Inc. (NASDAQ: HGSI), Novartis (NYSE: NVS) and GlaxoSmithKline (NYSE: GSK).
About Emerging Healthcare Solutions, Inc.
Emerging Healthcare Solutions, Inc. is a medical technology company that works to bring new and innovative medical technologies to the market. The Companya™s model is to engage a technology prior to its inflection point in order to maximize the profits available to EHSI as that new technology is adopted. Our common stock is traded under the symbol EHSI.
For more information, visit [ www.emerginghealthcaresolutionsinc.com ].
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
